Growth hormone and bone. Survey of the issue 1991-2001;Růstový hormon a kost přehled problematiky 1991-2001

Osteologicky Bulletin

Volumn 7, Issue 3, 2002, Pages 80-86

  Jensovsky J ^a  

^a CENTRAL MILITARY HOSPITAL   (Czech Republic)

Author keywords

Bone remodelling; Growth hormone; Insulin like growth factors

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN;

ARTICLE; ATHLETE; BONE GROWTH; BONE METABOLISM; BONE REMODELING; BONE TURNOVER; DRUG EFFECT; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; PROGNOSIS;

EID: 0036034716     PISSN: 12113778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Van der Veen EA, Netelenbos JC. Growth hormone therapy in adults: Bone and calcium metabolism. Horm Res 1990;33 suppl 4:65-8.
2. Wuster C, Slenczka E, Ziegler R. Erhohte praevalenz von osteoporose und arteriosklerose bei konventionell substituirter hypophysenvorderlappeninsufficienz: Bedarf einer zusantzlichen wachstumhormonsubstitution? Klin Wochenschr 1991;69:769-773.
3. Parfitt AM. Growth hormone and adult bone remodeling. Clin Endocrinol(Oxf). 1991,35;467-470.
4. Jensen LT, Jorgensen JOL, Ristelli J et al. Type I and type III procollagen propeptides in growth hormone deficient patients: Effects of increasing doses of GH. Acta Endocrinol 1991;124,278-282.
5. Schlemmer A, Johansen JS, Pedersen SA et al. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in Gh deficient adults. Clin Endocrinol. 1991:35,471-476.
6. Johansson AG, Burman P, Westermark K et al. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 1992;232:447-452.
7. Binnerts A, Swart GR, Wilson JHP et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrionol 1992;37:79-87.
8. Bing-You RG, Denis MC, Rosen CJ. Low bone mineral density in adults with previous hypothylamic-pituitary tumors: Correlations with serum growth hormone responses to GH releasing hormone, insulin-like growth factor I and IGF binding protein 3. Calcif Tissue Int 1993;52:183-187.
9. Thoren M, Soop M, Degerblad M et al. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteokalcin levels in adults with growth hormone deficiency. Acta Endocrinol 1993;128 suppl. 2:41-43.
10. Halloran DJ, Tsatsoulis A, Whitehouse RW et al. Increased bone density after recombinant human growth hormone therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993;76:1344-1348.
11. Vanderweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993;39:409-415.
12. Amato G, Carella C, Fazio S et al. Body composition, bone metabolism and heart structure and function in growth hormone deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 1993;77:1671-1676.
13. Sartorio A, Conti A, Monzani M et el. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest 1993;16:893-898.
14. Clemmesen B, Overgaard K, Riis B et al. Human growth hormone and growth hormone releasing hormone: A double-masked, placebo controlled study of their effects on bone metabolism in elderly women. Osteoporos Int 1993;3:330-336.
15. Holloway L, Butterfield G, Hintz RL et al. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. JCEM 1994;79:470-479.
16. Beshyah SA, Thomas E, Kyd P et al. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol 1994;40:383-391.
17. Juul A, Pedersen SA, Sorensen S et al. Growth hormone treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Europ J Endocrinol 1994;131:41-9.
18. Holmes S, Economou G, Whitehouse RW et al. Reduced bone mineral density in patients with adult onset growth hormone deficiency. JCEM 1994;78:669-674.
19. Ghiron LJ, Thompson JL, Holloway L et al: Effects of recombinant insulin-like growth factor I and growth hormone on bone turnover in elderly women. J Bone Mineral Res 1995;10:1844-1852.
20. Degerblad M, Bengtsson DM, Bramnert M et al. Reduced bone mineral density in adults with growth hormone deficiency: increased bone turnover during 12 month of GH substitution therapy. Europ J Endocrinol 1995;133:180-188.
21. Holmes SJ, Whitehouse RW, Swindell R et al. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 1995;42:627-633.
22. Balducci R, Toscano V, Pasquino AM et a. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long term growth hormone therapy. Europ J Endocrinol 1995;132:42-46.
23. Beshyah SA, Kyd P. Thomas E et al. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol 1995;42:249-254.
24. DeBoer H, Blok GJ, VanDer Veen EA. Clinical aspects of growth hormone deficiency. Endocrine Reviews 1995;16:63-86.
25. rd International hGH Symposium on Adult Replacement Therapy. Copenhagen 1995.
26. nd International hGH Symposium on Adult Replacement Therapy. Copenhagen 1995.
27. Valk NK, Erdtsieck RJ, Algra D et al. Combined treatment of growth hormone and the bisphosphonate pamidronate versus treatment with GH alone in GH deficient adults: The effects on renal phosphate handling, bone turnover and bone mineral mass. Clin Endocrinol 1995;43:317-324.
28. Johansson AG. Clinical studies on the role of growth hormone and insulin-like growth factor I in bone metabolism. Uppsala dissertations, Acta Universitatis Upsaliensis, 1995.
29. Bollerslev J, Moller J, Thomas S et al. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Eur J Endocrinol 1996;135:666-671.
30. Hansen TB, Brixen K, Vahl N et al. Effects of 12 month growth hormone treatment calciotrophic hormones, calcium homeostasis and bone metabolism in adults with aquired GH deficiency: A double blind, randomized, placebo-controlled study. JCEM 1996;81:3352-3359.
31. Weaver JU, Monson JP, Noonan K et al. The effect of low dose recombinant human growth hormone replacement on indices of bone remodelling and bone mineral density in hypopituitary growth hormone-deficient adults. Endocrinol Metab 1996;3:55-61.
32. Hull KL, Thiagarajah A, Harvey S. Cellular localization of growth hormone receptors/binding proteins in human tissues. Cell Tissue Res 1996;286:69-80.
33. Inzucchi SE, Robbins RJ: Growth hormone and maintenance of adult bone mineral density. Clin Endocrinol Oxf 1996;45:665-673.
34. Bravenboer N, Holzmann P, deBoer H et al. Histomorphmometric analysis of bone mass and bone metabolism in growth hormone deficient adult men. Bone 1996;18:551-557.
35. Hedner E, Linde A, Nilsson A. Systematically and locally administered groth hormone stimulates bone healing in combination with osteopromotive membranes: An experimental study in rats. J Bone Miner Res 1996;11:1952-1960.
36. Kohles SS, Cartee GD, Vanderby R. Cortical elasticity in ageing rats with and without growth hormone treatment. J Med Eng Technol 1996;20:157-163.
37. Johansson AG, Lindh E, Blum WF et al. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. JCEM 1996;81:44-48.
38. Johannsson G, Rosen T, Bosaeus I et al. Two years of growth hormone treatment increases bone mineral content and density in hypopituitary patients witrh adultonset GH deficiency. JCEM 1996;81:2865-2873.
39. Baum HBA, Biller BMK, Finkelstein JS et al. Effect of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Ann Intern Med 1996;125:883-890.
40. Amato G, Izzo G, La Montagna G et al. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clin Endocrinol 1996;45:27-32.
41. Sartono A, Ortolani S, Conti A et al. Effects of recombinant growth hormone treatment on bone mineral density and body composition in adults with childhood onset growth hormone deficiency. J Endocrinol Invest 1996;19:524-529.
42. Wright NM, Papadea N, Willi S et al. Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausa women. JCEM 1996;81:1023-1026.
43. Mauras N, Doi SQ, Shapiro JR. Recombinant human insulin-like growth factor I. recombinant human growth hormone and sex steroids: Effects on markers of bone turnover in humans. JCEM 1996;81:2222-2226.
44. Holmes SJ, Shalet SM. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res 1996;45:86-93.
45. Ho KK, O Sullivan AJ, Weissberger AJ et al. Sex steroid regulation of growth hormone secretion and action. Horm Res 1996;45:67-73.
46. Holmes SJ, Shalet SM. Adult growth hormone deficiency and bone mass. Horm Res 1996;Suppl 1:69-71.
47. Johansson AG, Eriksen EF, Lindh E et al. Reduced serum levels of growth hormone-dependent insulin-like growth factor binding protein and negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. JCEM 1997;82:2792-2794.
48. Wright NM, Papadea N, Wentz B et al. Increased serum 1,25-dihydroxyvitamin D after growth hormone administration is not parathyroid hormone mediated. Calcif. Tissue Int 1997;61:101-103.
49. Cuttica CM, Castoldi L, Gorrini GP et al. Effects of six-month administration of recombinant human growth hormone to healthy elderly subjects. Aging 1997;9:193-197.
50. Holloway L, Kohlmeier L, Kent K et al. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. JSEM 1997:82:1111-1117.
51. Marcus R. Skeletal effects of growth hormone and IGF-I in adults. Horm Res 1997:48 Suppl 5:60-64.
52. Magnusson P, Degerblad M, Saaf M et al. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res 1997;12:210-220.
53. Johannsson G, Bengtsson BA. Growth hormone and the acquisition of bone mass. Horm Res 1997;48:Suppl 5:72-77.
54. Johansson G. Growth Hormone Replacement in Growth Hormone Deficient Adults: Long Term Efficacy and Individual Responsiveness. PhD Thesis, Goteborg 1997.
55. Johannsson G, Jorgensen JOL, Russel-Jones DL et al. Treatment of GH deficiency in adults-bone tissue. 1998;Pharmacias. 14-17.
56. Finkenstedt G, Gasser RW, Hofle G et al. Effects of growth hormone replacement on bone metabolism and mineral density in adult onset of GH deficiency: Results of a double-blind placebo controlled study with open follow-up. Eur J Endocrinol 1997;136:282-289.
57. Vanderweghe M. Can we predict and prevent adult morbidity in males with childhood-onset growth hormone deficiency? Acta Paediatr Suppl 1997;423:121-123.
58. Toogood AA, Adams JE, O Neilly PA et al. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. JCEM 1997;82:1462-1466.
59. Christ ER, Corroll PV, Russell-Jones DL et al. The consequences of growth hormone deficiency in adulthood and the effects of growth hormone replacement. Schweiz Med Wochenschr 1997;127:1440-1449.
60. Burman P, Johansson AG, Siegbahn A et al. Growth hormone deficient men are more responsive to GH replacement therapy than women. JCEM 1997;82:550-555.
61. Bravenboer N, Holzmann P, de Boer H et al. The effect of growth hormone on histomorphometric indices of bone structure and bone turnover in GH deficient men. JCEM 1997;82:1818-1822.
62. Carroll PV, Christ ER, Bengtsson BA et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. JCEM 1998;83:382-395.
63. Ohlsson C, Bengtsson BA, Isaksson OG et al: Growth hormone and bone. Endocr Rev 1998;19:55-79.
64. Rosen CJ, Kurland SE, Vereault D et al. Association between serum insulin growth factor EI and simple sequence repeat in IGF-I gene: Implications for genetic studies of bone mineral density. JCEM 1998;83:2286-2290.
65. Russel-Aulet M, Shapiro B, Jaffe CA et al. Peak bone mass in young men is correlated with the magnitude of endogenous growth hormone secretion. JCEM 1998;83:3463-3468.
66. Fall C, Hindmarsh P, Dennison E et al. Programming of growth hormone secretion and bone mineral density in elderly men: A hypothesis. JCEM 1998;83:135-139.
67. Kotzmann H, Riedl M, Bernecker P et al. Effect of long term growth hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency. Calcif Tissue Int 1998;62:40-46.
68. Wuster C, Harle U, Rehn U et al. Benefits of growth hormone treatment on bone metabolism and bone strength in growth hormone deficiency and osteoporosis. Growth Hormone & IGF Research 1998;Suppl A:87-94.
69. Kann P, Piepkorn B, Schehler B et al. Effect of long term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH deficient adults. Clin Endocrinol 1998;48:561-568.
70. Gram J, Hansen TB, Jensen PB et al. The effect of recombinant human growth hormone treatment on bone and mineral metabolism in haemodialysis patients. Nephrology, Dialysis, Transplantation 1998;13:1529-1534.
71. Cuneo RC, Judd S, Wallace JD et al. The Australian Multicenter Trial of growth hormone treatment in GH deficient adults. JCEM 1998;83:107-116.
72. Bengtsson BA, Isaksson OG et al. Growth hormone and bone. Endocr Rev 1998;19:55-79.
73. Biondi T, Glatz Y, Bouillon R et al. Effects of short term insulin-like growth factor-I or growth hormone treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH deficient adults. JCEM 1998;83:81-87.
74. Johansson AG, Engstrom BE, Karlsson FA et al. Gender differences in the effects of long term growth hormone treatment on bone in adults with GH deficiency. JCEM 1999;84:2002-2007.
75. Colao AM, Di Somma C, Pivonello R et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. JCEM 1999;84:1919-1924.
76. Melhus H, Astrom G, Ahlstrom H et al. Use of novel biopsy system to study molecular effects of growth hormone in human bone - A pilot study. Iubmb Life 1999;48:175-178.
77. Murphy MG, Bach MA, Plotkin D et al. Oral administration of growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. J Bone Miner Res 1999;14:1182-1188.
78. Johansen PB, Nowak J, Skjaerbaek C et al. Ipamorelin, a new growth hormone releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Res 1999;9:106-113.
79. Crawford-Sharpe G, Rosen CJ. Insulin-like growth factor-I and the skeleton: New perspectives. The Endocrinologist 1999;9:81-86.
80. Valimaki MJ, Salmela PI, Samli J et al. Effects of 42 month of GH treatment on bone mineral density and bone turnover in GH deficient adults. Europ J Endocrinol 1999;140:545-554.
81. Longobardi S, Di Rella F, Pivonello R et al. Effects of two years of growth hormone replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. J Endocrinol Invest 1999;22:333-339.
82. Ortolani S. Bone densitometry: assesing the effects of growth hormone tretment in adults. Horm Res 2000;54:19-23.
83. Wuester C. Fracture rates in patients with growth hormone deficiency. Horm Res 2000;54:31-35.
84. Biller BMK, Sesmilo G, Baum HBA et al. Withdrawal of long term physiological growth hormone administration: Differential effects on bone density and body composition in men with adult onset GH deficiency. JCEM 2000;85:970-976.
85. Wallace JD, Cuneo RC, Lundberg PA et al. Responses of markers of bone and collagen turnover to exercise, growth hormone administration and GH withdrawal in trained adult males. JCEM 2000;85:124-133.
86. Longobardi S, Keay N, Ehrnborg C et al. Growth hormone effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: A double blind, placebo-controlled study. JCEM 2000;85:1505-1512.
87. Van Der Lely AJ, Lamberts SW, Jauch KW et al. Use of human GH in elderly patients with accidental hip fracture. Europ J Endocrinol 2000;143:585-592.
88. Bouillon R, Prodonova A. Growth and hormone deficiency and peak bone mass. J Paediatr Endocrinol Metab 2000;13:1327-1336.
89. Cowell CT, Woodhead HJ, Brody J. Bone markers and bone mineral density during growth hormone treatment in children with growth hormone deficiency. Horm Res 2000;54:44-51.
90. Clanget C, Seek T, Hinke V. et al. Effects of 6 years of growth hormone treatment on bone mineral density in GH deficient adults. Clin Endocrinol 2001;55:93-99.
91. Biermarsz NR, Hamdy NAT, Janssen YJH et al: Additional beneficial effets of alendronate in growth hormone deficient adults with osteoporosis receiving longterm recombinant human GH replacement therapy: A randomized controlled trial. JCEM 2001;86:3079-3080.
92. Murphy MG, Weiss S, McClung M et al. Effect of alendronate and MK-677, a growth hormone secretagogue, individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. JCEM 2001;86:1116-1125.
93. Wuester C, Abs R, Bengtssson B-A et al. The influence of growth hormone deficiency, growth hormone replacement therapy and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001;16:398-405.
94. Raschke M, Kolbeck S, Bail H et al. Homologous growth hormone accelerates healing of segmental bone defects. Bone 2001;29:368-373.
95. Banu MJ, Orhii PB, Wang L et al. Separate and combined effects of growth hormone and parathyroid hormone on cortical bone osteopenia in ovariectomized rats. Aging-Clinical and Experimental Research 2001;13:282-292.